We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Why Do Some People Continue to Eat When Full?

By HospiMedica International staff writers
Posted on 15 Jan 2010
A new study suggests that the "hunger hormone” ghrelin might make some people keep eating despite being sated by regulating extra homeostatic, hedonistic, aspects of eating behavior.

Researchers at the University of Texas (UT) Southwestern Medical Center (Dallas, USA) assessed the effects of different pharmacological, physiological, and genetic models of increased ghrelin and ghrelin-signaling blockade on two classic behavioral tests of reward behavior in mice: conditioned place preference (CPP), and operant conditioning. More...
In the first, they evaluated whether mice that were fully sated preferred a room where they had previously found high-fat food over one that had only offered regular, bland food. They found that when mice in this situation were administered ghrelin, they strongly preferred the room that had been paired with the high-fat diet. Mice without ghrelin, on the other hand, showed no preference. The researchers also found that blocking the action of ghrelin prevented the mice from spending as much time in the room they associated with the high-fat food. In the second test, the researchers observed how long mice would continue to poke their snout into a hole in order to receive a pellet of high-fat food. They found that the mice that did not receive ghrelin gave up much sooner than the ones that did receive ghrelin. The study was published ahead of print on December 23, 2009, in Biological Psychiatry.

"What we show is that there may be situations where we are driven to seek out and eat very rewarding foods, even if we're full, for no other reason than our brain tells us to,” said lead author Jeffrey Zigman, M.D., a UT assistant professor of internal medicine and psychiatry.

Ghrelin is a potent orexigenic hormone that is considered the counterpart of the hormone leptin (produced by adipose tissue), which induces satiation when present at higher levels. Ghrelin is produced mainly by cells lining the fundus of the human stomach and by the epsilon cells of the pancreas, and activates cells in the arcuate nucleus that include the orexigenic neuropeptide Y (NPY) neurons; Ghrelin-responsiveness of these neurones is both leptin- and insulin-sensitive. Ghrelin also activates the mesolimbic cholinergic-dopaminergic reward link, a circuit that communicates the hedonic and reinforcing aspects of natural rewards, such as food, as well as of addictive drugs, such as ethanol.

Related Links:
University of Texas (UT) Southwestern Medical Center


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.